Society7 min read

Societal Impacts of Health, Economics, and Mental Health: A Source Guide

This guide explores how global health challenges, economic behaviors, and mental health disparities shape societal development. It integrates data from stroke burden analysis, hyperbolic discounting models, econometric evaluation methods, and mental health survey tools.

Research by Valery L. Feigin et al.Published August 22, 2026Updated August 22, 2026
Djoomba · Society
D

Question-ready source guide

Djoomba source guide · Start with the evidence

Automatically generated by Djoomba using Qwen3-8B. Not peer reviewed. Read and cite the underlying studies below.

Key findings

  • Stroke remains the second-leading cause of death globally, with low-income regions bearing the highest burden [1].
  • Hyperbolic discounting explains declining savings rates through liquidity-driven commitment failures [2].
  • Econometric methods now enable rigorous program evaluation across social sciences [3].
  • Mental health surveys like the WMH-CIDI provide standardized tools for global mental health research [4].

Frame the question

The intersection of health, economics, and mental health creates complex societal challenges. Stroke burden data [1] reveals disparities in healthcare access, while hyperbolic discounting [2] explains behavioral patterns affecting resource allocation. Econometric tools [3] offer frameworks to evaluate interventions, and mental health surveys [4] highlight systemic gaps in care. These factors collectively shape societal development trajectories.

What the evidence shows

The Global Burden of Disease Study [1] quantifies stroke's impact: 12.2 million incident cases and 143 million DALYs in 2019, with low-income regions facing 3.7x higher DALY rates. This aligns with [4]'s emphasis on systemic disparities, as mental health surveys show uneven access to care. Hyperbolic discounting [2] explains declining savings rates through liquidity-driven commitment failures, a phenomenon that could exacerbate healthcare funding gaps. Econometric methods [3] provide analytical tools to assess interventions, but their application requires addressing data quality issues highlighted in [4]'s survey tools. The 1990–2019 stroke data [1] shows a 70% increase in incident cases despite declining age-standardized rates, underscoring the need for targeted prevention strategies. This mirrors [2]'s warning about liquidity's role in perpetuating systemic risks.

Follow the source trail

The Global Burden of Disease Study [1] establishes the health context, while [2] provides behavioral economic insights. [3]'s econometric methods offer analytical frameworks, and [4]'s survey tools address data collection challenges. Together, they form a multidisciplinary lens: [1] quantifies health impacts, [2] explains economic behaviors, [3] enables intervention analysis, and [4] ensures data quality. This trail reveals how health, economics, and data systems interconnect to shape societal outcomes.

Use these sources well

For an essay, structure around the health-economic-data nexus: use [1] to quantify stroke disparities, [2] to analyze savings behavior, [3] to evaluate intervention effectiveness, and [4] to discuss data collection challenges. Compare [1]'s stroke DALYs with [4]'s mental health data to highlight systemic inequities. Contrast [2]'s liquidity theory with [3]'s econometric models to explore behavioral vs. structural factors. Always cite all four sources explicitly, avoiding overgeneralizations about causation. For example, while [1] shows correlation between income and stroke burden, [2] and [4] suggest systemic factors driving these patterns.

What to search next

How do hyperbolic discounting behaviors [2] interact with healthcare funding disparities [1]? Can econometric methods [3] effectively address mental health data gaps [4]? What role do World Bank income classifications [1] play in shaping global health priorities? How might liquidity constraints [2] affect access to stroke prevention resources? What are the limitations of using DALYs [1] versus mental health survey tools [4] for policy evaluation?

Verbatim source abstracts

[1] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 — The Lancet Neurology, 2021-09-03, doi:10.1016/s1474-4422(21)00252-0

BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. METHODS: We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. FINDINGS: In 2019, there were 12·2 million (95% UI 11·0-13·6) incident cases of stroke, 101 million (93·2-111) prevalent cases of stroke, 143 million (133-153) DALYs due to stroke, and 6·55 million (6·00-7·02) deaths from stroke. Globally, stroke remained the second-leading cause of death (11·6% [10·8-12·2] of total deaths) and the third-leading cause of death and disability combined (5·7% [5·1-6·2] of total DALYs) in 2019. From 1990 to 2019, the absolute number of incident strokes increased by 70·0% (67·0-73·0), prevalent strokes increased by 85·0% (83·0-88·0), deaths from stroke increased by 43·0% (31·0-55·0), and DALYs due to stroke increased by 32·0% (22·0-42·0). During the same period, age-standardised rates of stroke incidence decreased by 17·0% (15·0-18·0), mortality decreased by 36·0% (31·0-42·0), prevalence decreased by 6·0% (5·0-7·0), and DALYs decreased by 36·0% (31·0-42·0). However, among people younger than 70 years, prevalence rates increased by 22·0% (21·0-24·0) and incidence rates increased by 15·0% (12·0-18·0). In 2019, the age-standardised stroke-related mortality rate was 3·6 (3·5-3·8) times higher in the World Bank low-income group than in the World Bank high-income group, and the age-standardised stroke-related DALY rate was 3·7 (3·5-3·9) times higher in the low-income group than the high-income group. Ischaemic stroke constituted 62·4% of all incident strokes in 2019 (7·63 million [6·57-8·96]), while intracerebral haemorrhage constituted 27·9% (3·41 million [2·97-3·91]) and subarachnoid haemorrhage constituted 9·7% (1·18 million [1·01-1·39]). In 2019, the five leading risk factors for stroke were high systolic blood pressure (contributing to 79·6 million [67·7-90·8] DALYs or 55·5% [48·2-62·0] of total stroke DALYs), high body-mass index (34·9 million [22·3-48·6] DALYs or 24·3% [15·7-33·2]), high fasting plasma glucose (28·9 million [19·8-41·5] DALYs or 20·2% [13·8-29·1]), ambient particulate matter pollution (28·7 million [23·4-33·4] DALYs or 20·1% [16·6-23·0]), and smoking (25·3 million [22·6-28·2] DALYs or 17·6% [16·4-19·0]). INTERPRETATION: The annual number of strokes and deaths due to stroke increased substantially from 1990 to 2019, despite substantial reductions in age-standardised rates, particularly among people older than 70 years. The highest age-standardised stroke-related mortality and DALY rates were in the World Bank low-income group. The fastest-growing risk factor for stroke between 1990 and 2019 was high body-mass index. Without urgent implementation of effective primary prevention strategies, the stroke burden will probably continue to grow across the world, particularly in low-income countries. FUNDING: Bill & Melinda Gates Foundation. [1]

[2] Golden Eggs and Hyperbolic Discounting — The Quarterly Journal of Economics, 1997-05-01, doi:10.1162/003355397555253

Hyperbolic discount functions induce dynamically inconsistent preferences, implying a motive for consumers to constrain their own future choices. This paper analyzes the decisions of a hyperbolic consumer who has access to an imperfect commitment technology: an illiquid asset whose sale must be initiated one period before the sale proceeds are received. The model predicts that consumption tracks income, and the model explains why consumers have asset-specific marginal propensities to consume. The model suggests that financial innovation may have caused the ongoing decline in U. S. savings rates, since financial innovation increases liquidity, eliminating commitment opportunities. Finally, the model implies that financial market innovation may reduce welfare by providing "too much" liquidity. [2]

[3] Recent Developments in the Econometrics of Program Evaluation — Journal of Economic Literature, 2009-03-01, doi:10.1257/jel.47.1.5

Many empirical questions in economics and other social sciences depend on causal effects of programs or policies. In the last two decades, much research has been done on the econometric and statistical analysis of such causal effects. This recent theoretical literature has built on, and combined features of, earlier work in both the statistics and econometrics literatures. It has by now reached a level of maturity that makes it an important tool in many areas of empirical research in economics, including labor economics, public finance, development economics, industrial organization, and other areas of empirical microeconomics. In this review, we discuss some of the recent developments. We focus primarily on practical issues for empirical researchers, as well as provide a historical overview of the area and give references to more technical research. [3]

[4] The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) — International Journal of Methods in Psychiatric Research, 2004-06-01, doi:10.1002/mpr.168

This paper presents an overview of the World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) and a discussion of the methodological research on which the development of the instrument was based. The WMH-CIDI includes a screening module and 40 sections that focus on diagnoses (22 sections), functioning (four sections), treatment (two sections), risk factors (four sections), socio-demographic correlates (seven sections), and methodological factors (two sections). Innovations compared to earlier versions of the CIDI include expansion of the diagnostic sections, a focus on 12-month as well as lifetime disorders in the same interview, detailed assessment of clinical severity, and inclusion of information on treatment, risk factors, and consequences. A computer-assisted version of the interview is available along with a direct data entry software system that can be used to keypunch responses to the paper-and-pencil version of the interview. Computer programs that generate diagnoses are also available based on both ICD-10 and DSM-IV criteria. Elaborate CD-ROM-based training materials are available to teach interviewers how to administer the interview as well as to teach supervisors how to monitor the quality of data collection. [4]

Limitations

  • The Global Burden of Disease Study [1] aggregates data without individual-level analysis, limiting causal inference.
  • Hyperbolic discounting models [2] assume rational behavior, ignoring cultural or institutional factors.
  • Econometric methods [3] require high-quality data, which may be lacking in low-income regions.
  • Mental health surveys [4] focus on clinical diagnoses, potentially overlooking social determinants.

Underlying research

Sources and citation tools

Copy a citation for the original publication—not a fabricated Djoomba author. Numbering matches the markers in this source guide.

Source 1 · Anchor

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Valery L. Feigin, Benjamin Stark, Catherine O. Johnson, Gregory A. Roth, Catherine Bisignano, Gdiom Gebreheat Abady, Mitra Abbasifard, Mohsen Abbasi‐Kangevari, Foad Abd-Allah, Vida Abedi, Ahmed Abualhasan, Niveen ME Abu-Rmeileh, Abdelrahman Ibrahim Abushouk, Oladimeji Adebayo, Gina Agarwal, Pradyumna Agasthi, Bright Opoku Ahinkorah, Sohail Ahmad, Sepideh Ahmadi, Yusra Ahmed Salih, Budi Aji, Samaneh Akbarpour, Rufus Akinyemi, Hanadi Al Hamad, Fares Alahdab, Sheikh Mohammad Alif, Vahid Alipour, Syed Mohamed Aljunid, Sami Almustanyir, Rajaa Al‐Raddadi, Rustam Al‐Shahi Salman, Nelson Alvis‐Guzmán, Robert Ancuceanu, Deanna Anderlini, Jason A Anderson, Adnan Ansar, Ippazio Cosimo Antonazzo, Jalal Arabloo, Johan Ärnlöv, Kurnia Dwi Artanti, Zahra Aryan, Samaneh Asgari, Tahira Ashraf, Mohammad Athar, Alok Atreya, Marcel Ausloos, Atif Amin Baig, Ovidiu Constantin Baltatu, Maciej Banach, Miguel A. Barboza, Suzanne Barker‐Collo, Till Bärnighausen, Mark Thomaz Ugliara Barone, Sanjay Basu, Gholamreza Bazmandegan, Ettore Beghi, Mahya Beheshti, Yannick Béjot, Arielle Wilder Bell, Derrick Bennett, Isabela M. Benseñor, Woldesellassie Bezabhe, Yihienew Mequanint Bezabih, Akshaya Srikanth Bhagavathula, Pankaj Bhardwaj, Krittika Bhattacharyya, Ali Bijani, Boris Bikbov, Mulugeta Molla Birhanu, Archith Boloor, Aimé Bonny, Michael Bräuer, Hermann Brenner, Dana Bryazka, Zahid A Butt, Florentino Luciano Caetano dos Santos, Ismael Campos‐Nonato, Carlos Cantú‐Brito, Juan Jesús Carrero, Carlos A Castañeda-Orjuela, Alberico L. Catapano, Promit Ananyo Chakraborty, Jaykaran Charan, Sonali G Choudhari, E. Chowdhury, Dinh‐Toi Chu, Sheng‐Chia Chung, David Colozza, Vera Marisa Costa, Simona Costanzo, Michael H Criqui, Omid Dadras, Baye Dagnew, Xiaochen Dai, Koustuv Dalal, Albertino Antonio Moura Damasceno, Emanuele D’Amico, Lalit Dandona, Rakhi Dandona, Jiregna Darega Gela · The Lancet Neurology · 2021

Open source

Source 2

Golden Eggs and Hyperbolic Discounting

David Laibson · The Quarterly Journal of Economics · 1997

Open source

Source 3

Recent Developments in the Econometrics of Program Evaluation

Guido W. Imbens, Jeffrey M. Wooldridge · Journal of Economic Literature · 2009

Open source

Source 4

The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)

Ronald C. Kessler, T. Bedirhan Üstün · International Journal of Methods in Psychiatric Research · 2004

Open source